Gene
VTCN1
V-set domain containing T cell activation inhibitor 1
Explore in graph →CI-GENE-00038642HGNC:28873 ENSG00000134258 NCBI 79679 Approved
Curated evidence
Clinical evidence (0)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
Data not yet available
No curated evidence item involves this gene yet.
Cohorts
Alteration frequency by cohort (8)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
cbioportalProvenance
- Source
- cBioPortal for Cancer Genomics (public studies)
- Dataset
- cBioPortal mutated genes by study
- Version
- cbioportal-2026-09-01
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- ODC Open Database License (ODC-ODbL) unless otherwise noted per study; attribution to the original studies required
- PMID
- 38995739
- Run
- ING-CBIOPORTAL-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Primary CNS Lymphoma (MSK, Clin Cancer Res 2024) pcnsl_msk_2024 | Primary Central Nervous System Lymphoma | Ssm | 3 | 86 | 3.5% | 118 | cbioportal |
| Mixed Tumors Selpercatinib RET Trial (MSK, Nat Commun. 2022) mixed_selpercatinib_2020 |
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.